Global Vaccines Innovation and Immunology Conference

The future of global health depends on continuous innovation in vaccines and immune science. GVX Immunology 2026 – Global Vaccines Innovation and Immunology Conference will be conducted from September 21–23, 2026, in London, United Kingdom, while extending online and hybrid participation to researchers and healthcare professionals around the world.
Designed as an international scientific forum, the Vaccine Conference 2026 welcomes specialists in vaccinology, immunology, infectious diseases, molecular biology, biotechnology, pharmaceutical sciences, clinical research, epidemiology, public health, and medical education. Participants will gain valuable knowledge about modern vaccine technologies, immune responses, translational medicine, monoclonal antibodies, immunogenetics, vaccine quality assessment, precision immunotherapy, laboratory innovation, and strategies supporting disease prevention.
The Immunology Congress creates an environment where researchers and professionals from academic institutions, healthcare organizations, biotechnology enterprises, pharmaceutical companies, and government agencies can exchange ideas and identify opportunities for future cooperation. Productive discussions encourage multidisciplinary research, scientific publications, technology development, and educational partnerships.
Remote attendees can actively participate through a comprehensive virtual platform featuring keynote lectures, research presentations, expert panel conversations, and networking opportunities. Whether joining from London or another country, delegates will experience a dynamic scientific programme that encourages collaboration, expands professional knowledge, and advances international efforts to improve vaccine research, immunology, and healthcare worldwide by Immunization Conferences.